|
RAPGEF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.09920969496125E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
7.592300E-04 |
| Normal-vs-Stage3 |
1.303190E-03 |
| Normal-vs-Stage4 |
3.284200E-02 |
| Stage1-vs-Stage2 |
1.773580E-01 |
| Stage1-vs-Stage3 |
2.12129999999089E-06 |
| Stage1-vs-Stage4 |
6.26730000008457E-07 |
| Stage2-vs-Stage3 |
1.324830E-01 |
| Stage2-vs-Stage4 |
5.518000E-02 |
| Stage3-vs-Stage4 |
4.798800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.41662287140343E-12 |
| Normal-vs-AfricanAmerican |
1.620310E-04 |
| Normal-vs-Asian |
6.951800E-02 |
| Caucasian-vs-AfricanAmerican |
2.433200E-01 |
| Caucasian-vs-Asian |
1.546600E-01 |
| AfricanAmerican-vs-Asian |
5.869000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.97030003423748E-09 |
| Normal-vs-Female |
2.99904545641994E-12 |
| Male-vs-Female |
1.268370E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.451600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.11342054967645E-12 |
| Normal-vs-Age(61-80Yrs) |
1.11310000106002E-08 |
| Normal-vs-Age(81-100Yrs) |
2.309200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.175400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.445000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.678800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.934100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.513800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.927370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.93620000000272E-05 |
| Normal-vs-Grade 2 |
2.66453525910038E-15 |
| Normal-vs-Grade 3 |
2.15420000004851E-06 |
| Normal-vs-Grade 4 |
6.610300E-02 |
| Grade 1-vs-Grade 2 |
6.018300E-04 |
| Grade 1-vs-Grade 3 |
1.62879999487942E-08 |
| Grade 1-vs-Grade 4 |
8.1250000061317E-09 |
| Grade 2-vs-Grade 3 |
8.195100000008E-05 |
| Grade 2-vs-Grade 4 |
2.04209999998817E-06 |
| Grade 3-vs-Grade 4 |
9.403600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
1.878820E-03 |
| ccA subtype-vs-ccB subtype |
2.36690000932072E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.79420003696163E-09 |
| Normal-vs-N1 |
4.047600E-01 |
| N0-vs-N1 |
1.799150E-01 |
|
|
